Thomson Reuters Corporation (TRI)
NasdaqGS • Currently up 1.36 (+1.29%) in today's trading session
1 member of Congress has disclosed 2 trades in Thomson Reuters Corporation (TRI) via STOCK Act filings. The most recent disclosure was a sale by John H. Rutherford on 17 February 2022. Aggregate disclosed activity totals roughly $16K in sales (midpoint estimates from bracketed disclosure amounts).
Thomson Reuters Corporation is currently trading at $106.14, positioned at 29% of its 52-week range ($76.28 – $180.00).
Want to automatically copy Pelosi trades?
Mirror Nancy Pelosi's portfolio with just one click on eToro.
Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.
Past Performance is not an indication of future results.
Thomson Reuters Corporation Price History and Technical Analysis
Congressional Trading Activity for TRI
| John H. Rutherford | 17 Feb 2022 | 16 Mar 2022 | Sale | Stock | $1,001 - $15,000 | N/A |
Select transactions to view their annotations on the chart
Similar Stocks
Based on congressional trading patterns
Frequently Asked Questions about TRI
- Which members of Congress have traded TRI?
- 1 member of Congress has disclosed 2 trade in Thomson Reuters Corporation (TRI) under the STOCK Act: John H. Rutherford.
- When was TRI most recently disclosed by Congress?
- The most recent TRI disclosure was a sale by John H. Rutherford on 17 February 2022.
- What is the total disclosed congressional trading volume for TRI?
- Members of Congress have disclosed approximately $16K in TRI sales (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
- How can I track new congressional trades in TRI?
- This TRI page updates as soon as new STOCK Act disclosures are filed for Thomson Reuters Corporation. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Track TRI in Congress
See when politicians buy or sell this stock